Global Drug Device Combination Products Market: Impact of COVID-19
Globally, as of 7 February 2022, there have been 394,381,395 confirmed cases of COVID-19, counting 5,735,179 deaths, reported to WHO. As of 6 February 2022, a total of 10,045,314,770 vaccine doses have been administered.
Moreover, the Covid-19 epidemic has affected the global economy and, in order to the market for drug-device combination products. By the end of the third quarter of 2020, isolation, travel restrictions and social distance measures are expected to lead to a significant reduction in business and consumer spending.
Request Here PDF Brochure Of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/3919
Global Drug Device Combination Products Market: Drivers
Furthermore, the rising rate of chronic diseases is probably going to boost the gloval market growth. In 2016, 2,221,188 cases of disseminated sclerosis (MS) were detected globally, in step with the Global Burden of Disease. The highest age-standardized MS per 100,000 persons was rated in Australasia (91.1), Western Europe (127.0), and North America (164.6). Oceania (2.0), Central Sub-Saharan Africa (2.8), and Eastern Sub-Saharan Africa (3.3) had the bottom rates.
Key players are that specialize in increasing their business or presence in unused markets, which facilitates market growth. Inomec, an Israel-based medical device company, was acquired in February 2020 by Integer Holdings Corporation, a medical device manufacturer and US-based medical device development company. Inomec focuses on the R&D and manufacture of medical devices, counting laser processing services, drug-device combination devices, metal implants, distribution systems, and minimally invasive devices. With this acquisition, Integer are ready to build an enquiry and development and sales center in Israel.
Market players are that specialize in developing and introducing new products in potential markets. for example, Terumo Corporation received the CE mark for the Ultimaster TANSEI drug-eluting stent in April 2018, which was introduced in Europe in May 2018. Additionally, the corporate aims to enlarge into the Asia, Latin America, and Middle East. Near future Also, India-based startup, vTitan Corporation announced the start of Accuflow SP-550 and Accuflow IBP-550 syringe infusion pumps in 2018. These pumps are designed for patients undergoing chemotherapy, surgical operation, or for patients whose dosage of medication must be precisely monitored and administered.
Global Drug Device Combination Products Market: Key Takeaways
- The size of the global drug device combination products market is forecast to be accounted at US$ 123.5 billion and over the estimated period (2020-2027) it is likely to witness a CAGR of 8.2%, due to the adoption of abiotic policies such as collaboration, partnership and acquisition. For example, Abbivie, Inc. purchased Allergan, a global pharmaceutical company, in June 2019 for about US$ 63 billion. As a result of this edit, Abbivie, Inc. increased its long-term R&D funding capacity, allowing investment to continue and a continued focus on advancing innovative science and industry-leading pipelines.
Global Drug Device Combination Products Market: Competitive Landscape
Key players performing in the global drug device combination products market are Flowonix Medical Inc., Haselmeier GmbH, Bausch Health Companies Inc., Teleflex Incorporated, Integer Holdings Corporation, Boston Scientific Corporation, Alcon Inc., Dickinson and Company, Becton, SINOMED, Kaleo Inc., Medtronic Plc., Abbott Laboratories, AbbVie Inc., and Teva Pharmaceutical Industries Ltd.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/3919
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Drug-device Combination Products Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Drug-device Combination Products Industry Impact
Chapter 2 Global Drug-device Combination Products Competition by Types, Applications, and Top Regions and Countries
2.1 Global Drug-device Combination Products (Volume and Value) by Type
2.3 Global Drug-device Combination Products (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Drug-device Combination Products Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Drug-device Combination Products Market Analysis
Chapter 6 East Asia Drug-device Combination Products Market Analysis
Chapter 7 Europe Drug-device Combination Products Market Analysis
Chapter 8 South Asia Drug-device Combination Products Market Analysis
Chapter 9 Southeast Asia Drug-device Combination Products Market Analysis
Chapter 10 Middle East Drug-device Combination Products Market Analysis
Chapter 11 Africa Drug-device Combination Products Market Analysis
Chapter 12 Oceania Drug-device Combination Products Market Analysis
Chapter 13 South America Drug-device Combination Products Market Analysis
Chapter 14 Company Profiles and Key Figures in Drug-device Combination Products Business
Chapter 15 Global Drug-device Combination Products Market Forecast (2022-2028)
Chapter 16 Conclusions
Research Methodology
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/3919
About US
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com